Enzolytics Inc (ENZC)

[Lolo12]

Enzolytics, Inc., Inc. is diligently working to bring its filings current and continue with its initiatives for the commercialization of its proprietary proteins for the treatment of HIV.

Enzolytics flagship compound ITV-1 (Immune Therapeutic Vaccine-1) is a suspension of Inactivated Pepsin Fraction (IPF), which studies have shown is effective in the treatment of HIV/AIDS. IPF is the active drug substance of ITV-1 and is a purified extract of porcine pepsin. ITV-1 has been shown to modulate the immune system. ITV-1 has also been shown to have anti-viral efficacy. Enzolytics continues to work with its Bulgarian partner, Immunotech Laboratories, BG, to complete the validation of the production process to submit the final documents to the Bulgarian drug agency in order to obtain registration.

About ENZOLYTICS;